TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
ImExHS Limited ( (AU:IME) ) just unveiled an announcement.
IMEXHS Limited announced that CEO Dr. German Arango will sacrifice approximately 50% of his salary for six months in exchange for nil-price options, pending shareholder approval. This move aligns the CEO’s interests with shareholders and reflects his commitment to the company’s future, as the Long Term Incentive Plan has not yet vested options to executives.
The most recent analyst rating on (AU:IME) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on ImExHS Limited stock, see the AU:IME Stock Forecast page.
More about ImExHS Limited
IMEXHS Limited is an innovative provider of medical imaging software and radiology services operating in 18 countries, including Colombia, the US, and Australia. Founded in 2012, the company offers cloud-based, vendor-neutral software solutions such as Picture Archiving and Communications System (PACS), Radiology Information System (RIS), Cardiology Information System (CIS), and Anatomical Pathology Laboratory Information System (APLIS). These solutions are designed to enhance productivity, save costs, and improve patient outcomes.
Average Trading Volume: 40,370
Technical Sentiment Signal: Sell
Current Market Cap: A$14.56M
Find detailed analytics on IME stock on TipRanks’ Stock Analysis page.